Small Pharma (CVE:DMT) Shares Down 11.7%

Small Pharma Inc. (CVE:DMT) shares fell 11.7% during trading on Thursday . The company traded as low as C$0.26 and last traded at C$0.27. 112,711 shares traded hands during mid-day trading, an increase of 37% from the average session volume of 82,052 shares. The stock had previously closed at C$0.30.

The company has a market capitalization of C$83.95 million and a price-to-earnings ratio of -1.73. The firm has a fifty day moving average price of C$0.39.

Small Pharma (CVE:DMT) last announced its earnings results on Friday, July 30th. The company reported C($0.02) EPS for the quarter, hitting the consensus estimate of C($0.02). Equities research analysts predict that Small Pharma Inc. will post -0.07 earnings per share for the current year.

Small Pharma Company Profile (CVE:DMT)

Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded in 2015 and is based in London, United Kingdom.

Recommended Story: What is a dead cat bounce?

Receive News & Ratings for Small Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Small Pharma and related companies with MarketBeat.com's FREE daily email newsletter.